Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion;Matrix-metalloproteinasen und deren inhibitoren bei lungenkarzinomen mit malignem pleuraerguss

Pneumologie

Volumn 59, Issue 8, 2005, Pages 523-528

  Moche, M ^a   Hui, D S C ^b   Huse, K ^a   Chan, K S ^c   Choy, D K L ^b   Scholz, G H ^a   Gosse, H ^d   Winkler, J ^a   Schauer, J ^a   Sack, U ^e   Hoheisel, Gerhard ^a,f  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Haven of Hope Hospital   (Hong Kong)

^d Robert Koch Klinik   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG CANCER; MALE; PLASMA; PLEURA EFFUSION; PRIORITY JOURNAL; ZYMOGRAPHY;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASES; PLEURAL EFFUSION, MALIGNANT; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 24144462221     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870966     Document Type: Article

References (31)

1. Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997; 10: 1907-1913
2. Light RW, Hamm H. Malignant pleural effusion: would the real cause please stand up? Eur Respir J 1997; 10: 1701-1712
3. Birkedal-Hansen H, Moore WGI, Bodden MK et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993; 4: 197-250
4. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis, and angiogenesis. Eur Respir J 1994; 7: 2062-2072
5. O'Connor CM, Fitzgerald MX. Matrix metalloproteases and lung disease. Thorax 1994; 49: 602-609
6. Crawford HC, Matrisian LM. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 1994; 14: 234-245
7. Hoheisel G, Sack U, Hui DSC et al. Occurrence of matrix metalloproteinases and tissue inhibitor of metalloproteinases in tuberculous Pleuritis. Tuberculosis 2001; 81: 203-209
8. Hoheisel G, Sack U, Hui DS et al. Immunohistochemische Lokalisierung von Matrixmetalloproteinasen (MMP) und Tissue inhibitors of metalloproteinases (TIMP) bei tuberkulöser Pleuritis. Pneumologie 2004; 58: 305-308
9. Hurewitz AN, Zucker S, Mancuso P et al. Human pleural effusions are rich in matrix metalloproteinases. Chest 1992; 102: 1808-1814
10. Hurewitz AN, Wu CL. Tetracydine and doxycycline inhibit pleural fluid metalloproteinases. Chest 1993; 103: 1113-1117
11. Eickelberg O, Sommerfeld CO, Wyser C et al. MMP and TIMP expression in pleural effusions of different origin. Am J Respir Crit Care Med 1997; 156: 1987-1992
12. Iglesias D, Alegre J, Aleman C et al. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Eur Respir J 2005; 25: 104-109
13. Iizasa T, Fujisawa T, Suzuki M et al. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients. Clin Cancer Res 1999; 5: 149-153
14. Ylisirnio S, Hoyhtya M, Turpeenniemi-Hujanen T. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer-TIMP-1 as a prognostic marker. Anticancer Res 2000; 20: 1311-1316
15. Hrabec E, Strek M, Nowak D et al. Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. Respir Med 2001; 95: 1-4
16. Laack E, Kohler A, Kugler C et al. Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer. Ann Oncol 2002; 13: 1550-1557
17. Tyagi SC, Matsubara L, Weber KT. Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 1993; 26: 191-198
18. Tyagi SC, Ratajyska A, Weber KT. Myocardial matrix metalloproteinase(s): Localisation and activation. Molec Cell Biochem 1993; 126: 49-59
19. Light RW, MacGregor MI, Luchsinger PC et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 72: 507-513
20. Marshall BC, Santana A, Xu QP et al. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest 1993; 91: 1792-1799
21. Karameris A, Panagou P, Tsilalis T et al. Association and expression of metalloproteinases and their inhibitors with the metastatic potential of squamous lung carcinomas: A molecular and immunohistochemical study. Am J Respir Crit Care Med 1997; 156: 1930-1936
22. Nakagawa H, Yagihashi S. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung. Jpn J Cancer Res 1994; 85: 934-938
23. Schütz A, Schneidenbach D, Aust G et al. Differential expression and activity status of MMP-1, MMP-2, MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung. Tumor Biol 2002; 23: 179-184
24. Canete-Soler R, Litzky L, Lubensky I et al. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridisation. Am J Pathol 1994; 144: 518-527
25. Urbanski SJ, Edwards DR, Maitland A et al. Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 1992; 66: 1188-1194
26. Zucker S, Hymowitz M, Conner C et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci 1999; 878: 212-227
27. Yoshikawa T, Suzuki K, Kobayashi O et al. Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma. Can To Kagaku Ryoho 1998; 25: 1461-1464
28. Baker T, Tickle S, Wasan H et al. Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer 1994; 70: 506-512
29. Sienel W, Hellers J, Morresi-Hauf A et al. Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer. Int J Cancer 2003; 103: 647-651
30. Garbisa S, Scagliotti G, Masiero L et al. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res 1992; 52: 4548-4549
31. Brown PD, Bloxridge RE, Stuart NSA et al. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small cell lung carcinoma. J Natl Cancer Inst 1993; 85: 574-578